Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir

J Oral Maxillofac Surg. 2011 Sep;69(9):2383-6. doi: 10.1016/j.joms.2010.10.040. Epub 2011 Feb 3.

Abstract

Purpose: We report a severe case of human papillomavirus-associated epithelial hyperplasia in a man infected with human immunodeficiency virus. These lesions were recalcitrant to treatment with surgical modalities and were eventually controlled with the daily application of a topical cidofovir gel.

Patient and methods: A single case is presented, along with a relevant review of the published data.

Results: Before the initiation of cidofovir treatment, the patient had approximately 80% of his gingiva and buccal mucosa engrossed by confluent papillomatous lesions. At 2 weeks after cidofovir treatment, the lesions had markedly regressed, and by 4 weeks, they were almost fully resolved. No untoward adverse reactions occurred.

Conclusions: Cidofovir formulated as a gel can be safe and effective for the treatment of epithelial hyperplasia in those with human immunodeficiency virus infection.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / complications
  • AIDS-Related Opportunistic Infections / drug therapy*
  • Antiviral Agents / therapeutic use*
  • Anus Neoplasms / complications
  • Cidofovir
  • Cytosine / analogs & derivatives*
  • Cytosine / chemistry
  • Cytosine / therapeutic use
  • Epithelium / pathology
  • Fatal Outcome
  • HIV Infections / complications*
  • Humans
  • Male
  • Middle Aged
  • Molecular Structure
  • Mouth Diseases / drug therapy*
  • Mouth Diseases / virology*
  • Mouth Mucosa / pathology
  • Organophosphonates / chemistry
  • Organophosphonates / therapeutic use*
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / drug therapy*

Substances

  • Antiviral Agents
  • Organophosphonates
  • Cytosine
  • Cidofovir